Tolerability, pharmacokinetics and pharmacodynamics of ADC 3680 in volunteers and asthmatic patients

Trial Profile

Tolerability, pharmacokinetics and pharmacodynamics of ADC 3680 in volunteers and asthmatic patients

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Apr 2014

At a glance

  • Drugs ADC 3680 (Primary) ; Corticosteroids
  • Indications Allergic asthma
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 29 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top